Being client centered organization, we are established as exporter and wholesaler of Bevacizumab Injection. This offered medication is utilized as a part of blend with other hostile to tumor drugs in the treatment of growths of substantial gut, bosoms, lung, kidney, cervix, ovaries, fallopian tubes and peritoneum. These medicines are prepared by using premium quality components with the assistance of modern techniques under the stern inspection of experienced team of physicians. Further, Bevacizumab Injection are available at industry driving costs delivery within secured time frame.
A drug called bevacizumab injection is used to treat several forms of cancer. It is a member of the monoclonal antibody medication class. Vascular endothelial growth factor (VEGF), a protein that encourages the formation of new blood vessels within tumours, is a target that bevacizumab, particularly targets and inhibits.Bevacizumab aids in inhibiting the growth of new blood vessels in tumours by blocking VEGF, decreasing their blood supply and food intake. This may result in the inhibition of tumour growth and even the possibility of tumour regression.
Several tumours, including colorectal cancer, lung cancer, ovarian cancer, and renal cell carcinoma, are treated with bevacizumab. Under the direction of a healthcare practitioner, intravenous infusion is commonly used to give it.Bevacizumab can have side effects like hypertension, haemorrhage, proteinuria, and gastrointestinal perforation, much like any other medicine. A healthcare professional should decide how to use and dose bevacizumab based on the particular type and stage of cancer that is being treated.
Bevacizumab Injection is a medication that belongs to a class of drugs called monoclonal antibodies. It is used for the treatment of various cancers and certain eye conditions. Bevacizumab targets a protein called vascular endothelial growth factor (VEGF), which plays a role in the formation of new blood vessels that supply tumors.
Bevacizumab is primarily used in the treatment of different types of cancers, including colorectal cancer, lung cancer, breast cancer, kidney cancer, ovarian cancer, and glioblastoma (a type of brain cancer). It is also used for certain eye conditions such as macular degeneration and diabetic retinopathy.
Bevacizumab Injection is typically administered by a healthcare professional through intravenous (IV) infusion. The dosage and frequency of administration depend on the specific condition being treated, the patient's overall health, and the healthcare provider's instructions.
Bevacizumab Injection may cause various side effects, which can vary from person to person. Common side effects include high blood pressure, bleeding or clotting disorders, gastrointestinal perforation, impaired wound healing, proteinuria (increased protein in the urine), and increased risk of infections. It is important to discuss potential side effects with a healthcare professional before starting treatment.